Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.28 USD | -1.58% | +1.29% | +3.88% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.68B | Capitalization | 20.85B |
---|---|---|---|---|---|
Net income 2024 * | 747M | Net income 2025 * | 960M | EV / Sales 2024 * | 1.99 x |
Net Debt 2024 * | 9.15B | Net Debt 2025 * | 8.02B | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
18.1
x | Employees | 60,000 |
Yield 2024 * |
2.83% | Yield 2025 * |
3.05% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | -2.52% | ||
1 week | +0.48% | ||
Current month | -6.79% | ||
1 month | -4.67% | ||
3 months | +2.18% | ||
6 months | +23.88% | ||
Current year | +3.05% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 215 M€ | +12.36% | - | |
1.23% | 18 M€ | +3.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 40.15 | -1.91% | 2 177 986 |
24-04-24 | 40.93 | -0.22% | 2,161,941 |
24-04-23 | 41.02 | +1.53% | 2,646,343 |
24-04-22 | 40.4 | +2.36% | 3,272,883 |
24-04-19 | 39.47 | -0.45% | 2,808,386 |
Delayed Quote Nyse, April 25, 2024 at 12:45 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.05% | 20.85B | |
-3.07% | 185B | |
-3.73% | 107B | |
-5.31% | 67.55B | |
+10.11% | 54.6B | |
+17.17% | 47.42B | |
+3.86% | 42.24B | |
+6.31% | 28.24B | |
+0.51% | 26.42B | |
+12.40% | 25.66B |
- Stock Market
- Equities
- BAX Stock